NCT00736541View on ClinicalTrials.gov

N-acetylcysteine in Liver Transplantation

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

January 31, 2008

Conditions
End Stage Liver Failure
Interventions
DRUG

N-acetylcysteine

The patients in the NAC group will receive a loading dose of 140 mg/kg IV of NAC over one hour at the start of the surgery. Thereafter, NAC will be repeated every 4 hours at a dose of 70 mg/kg IV, for a total of 13 doses

Trial Locations (1)

15213

Unversity of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
lead

Ibtesam Hilmi

OTHER

NCT00736541 - N-acetylcysteine in Liver Transplantation | Biotech Hunter | Biotech Hunter